Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBI-001 in Healthy Participants and Hereditary Hemochromatosis
NCT07371793Phase 2Recruiting
- Sponsor
- Bond Biosciences
- Start
- May 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BBI-001 in hereditary hemochromatosis (HH), sponsored by Bond Biosciences. Started May 2026; status: recruiting.
02
Drugs
BBI-001
03
Conditions
hereditary hemochromatosis (HH)
Beyond the preview
Go deeper on NCT07371793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07371793.